None listed
Conditions
Interventions
Dietary Supplement : Eeah group takes either placebo or Acanthopanax extract twice a day for 12 weeks
Sponsors
Dongguk University Ilsan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject who agrees to participate and signs informed consent form 2) Age: 20~65 years 3) Subject who has more than 2 risk factors of cardiovascular disease as follows: smoking, high blood pressure, high blood lipid level.
Exclusion criteria
Exclusion criteria: 1) Subject with high level of physical activity 2) Woman who is postmenopausal or under hormone therapy. 3) Subject whose body weight changes more than 10% within 8 weeks prior to first visit or who is controlling the body weight. 4) BMI =35kg/m2 5) Subject with diseases as follows: cardiovascular disease, diabetes mellitus, thyroid gland dysfunction, infectious diseases, renal diseases, hepatic diseases, etc. 6) Subject who is predicted to use prohibited drugs or consumption of oriental medicine during the experimental period 7) Subject with hypersensitivity to test materials 8) Consumption of dietary supplements that can affect cardiovascular function within 4 weeks prior to the first visit 9) Participation in other human study within 12 weeks prior to the first visit 10) Pregnant or lactating woman 11) Any condition that the principal investigator believes may put the subjects at undue risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Marker of blood flow ;Blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| Makers of inflammation | — |
Countries
Korea, Republic of
Contacts
Public ContactKyung-ha Lee
Dongguk University Ilsan Hospital
Outcome results
None listed